Stents farmacológicos para o tratamento de coronárias de fino calibre: experiência muito tardia (até 7 anos) do Registro DESIRE [PDF]
INTRODUCAO: Neste estudo, buscamos avaliar os resultados clinicos de pacientes com lesoes coronarias em vasos de fino calibre, numa coorte de pacientes do mundo real submetidos a intervencao coronaria percutânea (ICP) com stents farmacologicos.
Ederlon Ferreira Nogueira+8 more
openalex +2 more sources
Resultados iniciais e tardios de diabéticos tratados com stents farmacológicos do Registro Safira [PDF]
BACKGROUND: The percutaneous treatment of coronary artery disease has been revolutionized by the use of drug-eluting stents (DES). However, its use in the daily practice involves patients with more complex clinical and angiographic characteristics than ...
Julio Flávio+16 more
openalex +2 more sources
Uso do escore de propensão na análise de custo-efetividade com utilização seletiva de stents farmacológicos e não-farmacológicos [PDF]
BACKGROUND: Studies on the cost-effectiveness ratio of drug-eluting stents (DES) are rare. Our objective was to evaluate the results and compare costs (incremental cost-effectiveness ratio - ICER) per restenosis avoided between DES and bare metal stents (
Esmeralci Ferreira+9 more
openalex +2 more sources
Evolução clínica de pacientes com lesões de tronco de coronária esquerda não-protegido submetidos a angioplastia coronária com implante de stents farmacológicos [PDF]
INTRODUCAO: Recentemente a intervencao coronaria percutânea (ICP) com stents farmacologicos (SFs) tem se mostrado uma opcao viavel em pacientes selecionados com lesao de tronco de coronaria esquerda nao-protegido (TCE-NP).
Costantino Costantini+9 more
openalex +2 more sources
Impacto da disponibilização de stents farmacológicos para pacientes do Sistema Único de Saúde nas indicações de revascularização miocárdica [PDF]
BACKGROUND: Drug-eluting stents (DES) are still not accessible for patients from the Public Healthcare System (PuHS). This study aimed to evaluate how the availability of DES for use in PuHS patients could impact the conduct of the interventional ...
Rodrigo Lagny de Castro Oliveira+5 more
openalex +2 more sources
Stents Farmacológicos para Todos: o Preço Vale a Pena? [PDF]
Marcos Danillo P Oliveira+2 more
doaj +4 more sources
Evolução tardia de pacientes com infarto agudo do miocárdio tratados com stents farmacológicos na prática diária do mundo real: subanálise do Registro DESIRE (Drug-Eluting Stent In the REal World) [PDF]
BACKGROUND: Previous studies comparing drug-eluting stents (DES) and bare-metal stents suggest efficacy and safety of the DES in the treatment of patients with myocardial infarction (MI).
Ricardo A. Costa+11 more
openalex +2 more sources
Stents farmacológicos vs. stents não-farmacológicos no tratamento de enxertos de veia safena [PDF]
BACKGROUND: Although drug-eluting stents have markedly reduced restenosis and the need for repeat lesion revascularization in the vast majority of clinical and angiographic scenarios, the benefit of these devices for the treatment of saphenous-vein graft
Carlos Collet+12 more
openalex +2 more sources
Evolução tardia após intervenção coronária percutânea com stents farmacológicos em pacientes diabéticos do Registro DESIRE (Drug-Eluting Stents In the REal world) [PDF]
BACKGROUND: Diabetes mellitus is related to the occurrence of unfavorable outcomes after percutaneous coronary interventions. Drug-eluting stents can confer a better late evolution to this subgroup.
Adriana Moreira+11 more
openalex +2 more sources
O uso de stents farmacológicos no tratamento da estenose das artérias vertebrais [PDF]
OBJECTIVE: To report the feasibility and safety of percutaneous transluminal angioplasty with paclitaxel-eluting stents for management of vertebral artery stenosis in 14 patients, after two-year follow-up.
Eduardo Wajnberg+2 more
semanticscholar +2 more sources